TITLE

Serum sLOX-1 levels are associated with the presence and severity of angiographic coronary artery disease in patients with metabolic syndrome

AUTHOR(S)
Bo Li; Li-hua Zhang; Xin-guo Yang; Xiong-tao Liu; Yin-gang Ren
PUB. DATE
December 2010
SOURCE
Clinical & Investigative Medicine;Dec2010, Vol. 33 Issue 6, pE398
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: Patients with metabolic syndrome are at high-risk for development of atherosclerosis and cardiovascular events. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1(sLOX-1) is associated with coronary artery disease (CAD) and metabolic disorders. We sought to assess whether serum sLOX-1 levels are correlated with the presence and severity of CAD in patients with metabolic syndrome (MetS) undergoing coronary angiography. Methods: Serum sLOX-1 levels were measured in 112 consecutive patients with MetS, undergoing coronary angiography for the evaluation of CAD. !e severity of CAD was assessed by angiographic Gensini score system. Results: Serum sLOX-1 levels were significantly higher in MetS patients with CAD (n=69) than in those without CAD (n=43) (0.925 [range 0.137 to 1.432] ng/ml vs. 0.207 [range 0.063 to 0.774] ng/ml, P<0.01). Multivariate logistic regression analysis revealed that serum sLOX-1 level was independently associated with the presence of CAD (odds ratio 2.489, 95% confidence interval 1.290-4.802; P<0.01). Serum sLOX-1 levels were positively correlated with the Gensini score (#: 0.394, <0.01) after adjusting for other clinical characteristics. Conclusions: High sLOX-1 levels are associated with the presence and severity of CAD in patients with MetS. !e measurement of serum sLOX-1may be potentially useful in predicting the presence and severity of CAD in patients with MetS.
ACCESSION #
61180833

 

Related Articles

  • Resting Heart Rate and Coronary Artery Calcium in Postmenopausal Women. Allison, Matthew A.; Manson, JoAnn E.; Aragaki, Aaron; Eaton, Charles B.; Hsai, Judith; Phillips, Lawrence; Kuller, Lewis; Trevisan, Maurizio // Journal of Women's Health (15409996);May2011, Vol. 20 Issue 5, p661 

    Objective: To test the hypothesis of a significant association between resting heart rate (RHR) and coronary artery calcium (CAC). Methods: This is a cross-sectional study of a subset of women enrolled in the estrogen-alone clinical trial of the Women's Health Initiative (WHI). We used a...

  • Abstracts: International Heart Forum. Beijing, China, August 11-14, 2011.  // Cardiology;Dec2011 Supplement, Vol. 120, p1 

    No abstract available

  • New Roles for Antiplatelet Agents in Treatment of Atherothrombotic Diseases. Bottorff, Michael B. // Journal of the American Pharmacists Association: JAPhA;Mar/Apr2004 Supplement 1, Vol. 44, pS4 

    Focuses on the roles of antiplatelet agents in the treatment of atherothrombotic diseases. Information on atherogenesis; Facets of the systemic disease process; Treatment of atherosclerotic disease.

  • Coronary artery disease – is menopause a risk factor? Gohlke-Bärwolf, C. // Basic Research in Cardiology;Nov2000 Supplement 1, Vol. 95, pI77 

    Cardiovascular disease, especially coronary artery disease (CAD), are leading causes of morbidity and mortality in women over the age of 50, whereas this is rarely the case in younger women. This fact, the overall lower incidence of and the 10–15 year retarded occurrence of CAD in women,...

  • ASPECTS REGARDING THE INTERRELATION BETWEEN DYSLIPIDEMIA AND SILENT ISCHEMIC HEART DISEASE. Bălaj, Gabriela; Lazăr, Aurel; Farkas-Pall, Zsuzsanna // Acta Medica Transilvanica;jun2011, Vol. 16 Issue 2, p221 

    Dyslipidemia is a real public health problem worldwide, which is justified by its increased prevalence and incidence, its complex pathogenic and clinical consequences, as well as the costs involved. Dyslipidemia does not cause direct clinical manifestations, but is a major risk factor for...

  • Key Global Literature. Fonseca, Vivian // Diabetes Care;May2005, Vol. 28 Issue 5, p1270 

    Presents abstract of the article "The Metabolic Syndrome and Coronary Heart Disease in Older Women: Findings From the British Women's Heart and Health Study," by D. A. Lawlor, S. Ebrahim and G. Davey Smith, published in the 2004 issue of the "Diabetic Medicine."

  • Traditional Risk Factors in Hypertensive Women and Men with Ischemic Heart Disease. Dalma, Szentendrey; Preg, Z.; Márta, Germán Salló; Mihaela, Hubatsch; Andreea, Bocicor; Farkas, L.; Dósa, G. // Acta Medica Marisiensis;Oct2011, Vol. 57 Issue 5, p524 

    Background: Ischemic heart disease is the main cause of morbidity and mortality in Europe. It occurs often in women, and its prevalence increases with age. Hypertensive patients with coronary heart disease are at highest risk and thus are the most important target of secondary prevention...

  • Job Decision Latitude, Job Demands, and Cardiovascular Disease: A Prospective Study of Swedish Men. Karasek, Robert; Baker, Dean; Marxer, Frank; Ahlbom, Anders; Theorell, Tores // American Journal of Public Health;Jul1981, Vol. 71 Issue 7, p694 

    Abstract: The association between specific job characteristics and subsequent cardiovascular disease was tested using a large random sample of the male working Swedish population. The prospective development of coronary heart disease (CHD) symptoms and signs was analyzed using a multivariate...

  • Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S). Pyörälä, Kalevi; Ballantyne, Christie M.; Gumbiner, Barry; Lee, Michael W.; Shah, Arvind; Davies, Michael J.; Mitchell, Yale B.; Pedersen, Terje R.; Kjekshus, John; Pyörälä, Kalevi; Mitchel, Yale B; Scandinavian Simvastatin Survival Study (4S) // Diabetes Care;Jul2004, Vol. 27 Issue 7, p1735 

    Objective: To assess the effect of simvastatin treatment on the risk of cardiovascular events in nondiabetic patients with coronary heart disease (CHD) with and without the metabolic syndrome, as defined by the National Cholesterol Education Program (NCEP) Adult Treatment Panel III...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics